These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 32375305)

  • 1. Early-Life Respiratory Syncytial Virus Infection, Trained Immunity and Subsequent Pulmonary Diseases.
    Malinczak CA; Lukacs NW; Fonseca W
    Viruses; 2020 May; 12(5):. PubMed ID: 32375305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunostimulatory Defective Viral Genomes from Respiratory Syncytial Virus Promote a Strong Innate Antiviral Response during Infection in Mice and Humans.
    Sun Y; Jain D; Koziol-White CJ; Genoyer E; Gilbert M; Tapia K; Panettieri RA; Hodinka RL; López CB
    PLoS Pathog; 2015 Sep; 11(9):e1005122. PubMed ID: 26336095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory Syncytial Virus Infection Upregulates NLRC5 and Major Histocompatibility Complex Class I Expression through RIG-I Induction in Airway Epithelial Cells.
    Guo X; Liu T; Shi H; Wang J; Ji P; Wang H; Hou Y; Tan RX; Li E
    J Virol; 2015 Aug; 89(15):7636-45. PubMed ID: 25972545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Affecting the Immunity to Respiratory Syncytial Virus: From Epigenetics to Microbiome.
    Fonseca W; Lukacs NW; Ptaschinski C
    Front Immunol; 2018; 9():226. PubMed ID: 29515570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early-life pulmonary viral infection leads to long-term functional and lower airway structural changes in the lungs.
    Malinczak CA; Fonseca W; Hrycaj SM; Morris SB; Rasky AJ; Yagi K; Wellik DM; Ziegler SF; Zemans RL; Lukacs NW
    Am J Physiol Lung Cell Mol Physiol; 2024 Mar; 326(3):L280-L291. PubMed ID: 38290164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate immune responses in respiratory syncytial virus infections.
    Krishnan S; Halonen M; Welliver RC
    Viral Immunol; 2004; 17(2):220-33. PubMed ID: 15279701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus.
    Lee Y; Ko EJ; Kim KH; Lee YT; Hwang HS; Kwon YM; Graham BS; Kang SM
    Virology; 2019 Aug; 534():1-13. PubMed ID: 31163351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
    Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Respiratory Syncytial Virus Nonstructural Protein 2 Residues Essential for Exploitation of the Host Ubiquitin System and Inhibition of Innate Immune Responses.
    Whelan JN; Tran KC; van Rossum DB; Teng MN
    J Virol; 2016 Jul; 90(14):6453-6463. PubMed ID: 27147743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary Susceptibility of Neonates to Respiratory Syncytial Virus Infection: A Problem of Innate Immunity?
    Drajac C; Laubreton D; Riffault S; Descamps D
    J Immunol Res; 2017; 2017():8734504. PubMed ID: 29250560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GBP5 Is an Interferon-Induced Inhibitor of Respiratory Syncytial Virus.
    Li Z; Qu X; Liu X; Huan C; Wang H; Zhao Z; Yang X; Hua S; Zhang W
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32796072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent respiratory syncytial virus infections in allergen-sensitized mice lead to persistent airway inflammation and hyperresponsiveness.
    Matsuse H; Behera AK; Kumar M; Rabb H; Lockey RF; Mohapatra SS
    J Immunol; 2000 Jun; 164(12):6583-92. PubMed ID: 10843718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathogenesis of respiratory syncytial virus disease in childhood.
    McNamara PS; Smyth RL
    Br Med Bull; 2002; 61():13-28. PubMed ID: 11997296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of Dendritic Cells in Protective Immunity against Respiratory Syncytial Virus Infection.
    Jung HE; Kim TH; Lee HK
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31952261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of Respiratory Syncytial Virus (RSV) Memphis Strain 37 (M37) Infection in the Respiratory Tract of Newborn Lambs as an RSV Infection Model for Human Infants.
    Larios Mora A; Detalle L; Van Geelen A; Davis MS; Stohr T; Gallup JM; Ackermann MR
    PLoS One; 2015; 10(12):e0143580. PubMed ID: 26641081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory syncytial virus (RSV) infects neuronal cells and processes that innervate the lung by a process involving RSV G protein.
    Li XQ; Fu ZF; Alvarez R; Henderson C; Tripp RA
    J Virol; 2006 Jan; 80(1):537-40. PubMed ID: 16352577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection.
    Piedimonte G
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S66-74; discussion S74-5. PubMed ID: 12671455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual proinflammatory and antiviral properties of pulmonary eosinophils in respiratory syncytial virus vaccine-enhanced disease.
    Su YC; Townsend D; Herrero LJ; Zaid A; Rolph MS; Gahan ME; Nelson MA; Rudd PA; Matthaei KI; Foster PS; Dent L; Tripp RA; Lee J; Simson L; Mahalingam S
    J Virol; 2015 Feb; 89(3):1564-78. PubMed ID: 25410867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity.
    Sarkar I; Garg R; van Drunen Littel-van den Hurk S
    Vaccine; 2016 Sep; 34(42):5114-5124. PubMed ID: 27591951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Alterations to the CX3C Motif and Secreted Form of Human Respiratory Syncytial Virus (RSV) G Protein on Immune Responses to a Parainfluenza Virus Vector Expressing the RSV G Protein.
    Liang B; Kabatova B; Kabat J; Dorward DW; Liu X; Surman S; Liu X; Moseman AP; Buchholz UJ; Collins PL; Munir S
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.